{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Clarence",
      "state": "NY",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "89779",
      "recalling_firm": "Athenex Pharma Solutions, LLC",
      "address_1": "11342 Main St",
      "address_2": "N/A",
      "postal_code": "14031-1718",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "USA nationwide.",
      "recall_number": "D-0712-2022",
      "product_description": "Epinephrine Injection 8 mg per 250 mL in 0.9% Sodium Chloride, 8mg, 250 mL excel bag, Rx only, Athenex Pharma Solutions, LLC, Clarence, NY, 14031, NDC 76154-814-15",
      "product_quantity": "N/A",
      "reason_for_recall": "Defective container",
      "recall_initiation_date": "20220314",
      "center_classification_date": "20220321",
      "termination_date": "20220804",
      "report_date": "20220330",
      "code_info": "Lot #: F2101780, F2101781, Exp 6/21/22"
    }
  ]
}